Staphylococcus aureus surgical site infection rates in 5 European countries

Author:

Mellinghoff Sibylle C.ORCID,Bruns Caroline,Albertsmeier MarkusORCID,Ankert JulianeORCID,Bernard LouisORCID,Budin Sofia,Bataille CamilleORCID,Classen Annika Y.ORCID,Cornely Florian B.,Couvé-Deacon ElodieORCID,Fernandez Ferrer Maria,Fortún JesúsORCID,Galar AliciaORCID,Grill Eva,Guimard Thomas,Hampl Jürgen A.,Wingen-Heimann SebastianORCID,Horcajada Juan P.ORCID,Köhler Felix,Koll Carolin,Mollar Joan,Muñoz PatriciaORCID,Pletz Mathias W.,Rutz Jule,Salmanton-García Jon,Seifert Harald,Serracino-Inglott FerdinandORCID,Soriano Alex,Stemler JannikORCID,Vehreschild Janne J.ORCID,Vilz Tim O.ORCID,Naendrup Jan-HendrikORCID,Cornely Oliver A.ORCID,Liss Blasius J.ORCID

Abstract

Abstract Objective To determine the overall and procedure-specific incidence of surgical site infections (SSI) caused by Staphylococcus aureus (S. aureus) as well as risk factors for such across all surgical disciplines in Europe. Methods This is a retrospective cohort of patients with surgical procedures performed at 14 European centres in 2016, with a nested case–control analysis. S. aureus SSI were identified by a semi-automated crossmatching bacteriological and electronic health record data. Within each surgical procedure, cases and controls were matched using optimal propensity score matching. Results A total of 764 of 178 902 patients had S. aureus SSI (0.4%), with 86.0% of these caused by methicillin susceptible and 14% by resistant pathogens. Mean S. aureus SSI incidence was similar for all surgical specialties, while varying by procedure. Conclusions This large procedure-independent study of S. aureus SSI proves a low overall infection rate of 0.4% in this cohort. It provides proof of principle for a semi-automated approach to utilize big data in epidemiological studies of healthcare-associated infections. Trials registration The study was registered at clinicaltrials.gov under NCT03353532 (11/2017).

Funder

Universitätsklinikum Köln

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3